Pradeep Babu Sadasivan Pillai - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Endocrine Connections|October 7, 2017

Sitagliptin 100 mg vs glimepiride 1-3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)Jothydev Kesavadev, Pradeep Babu Sadasivan Pillai, Arun Shankar, et al.

Diabetes Technology & Therapeutics|June 28, 2012

Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus--a retrospective studyJothydev Kesavadev, Arun Shankar, Pradeep Babu Sadasivan Pillai, et al.

Advances in Therapy|July 2, 2017

Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective EvaluationJothydev Kesavadev, Robert Vigersky, John Shin, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Endocrine Connections|October 7, 2017

Sitagliptin 100 mg vs glimepiride 1-3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)Jothydev Kesavadev, Pradeep Babu Sadasivan Pillai, Arun Shankar, et al.

Diabetes Technology & Therapeutics|June 28, 2012

Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus--a retrospective studyJothydev Kesavadev, Arun Shankar, Pradeep Babu Sadasivan Pillai, et al.

Advances in Therapy|July 2, 2017

Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective EvaluationJothydev Kesavadev, Robert Vigersky, John Shin, et al.

Pageof 1